Methods in Cancer Biostatistics Workshop:
Clinical Trial Designs for Targeted Agents

An intensive workshop designed specifically for biostatisticians interested in applying their statistical knowledge to oncology clinical trials

June 7-13, 2015
Resort at Squaw Creek
Lake Tahoe, California

Workshop Chairperson
Steven Piantadosi, Cedars-Sinai Medical Center, Los Angeles, California

Organizing Committee
Monica Marie Bertagnolli, Brigham & Women's Hospital, Boston, Massachusetts
John J. Crowley, Cancer Research and Biostatistics, Seattle, Washington
Robert A. Figlin, Cedars-Sinai Medical Center, Los Angeles, California
Susan G. Hilsenbeck, Baylor College of Medicine Cancer Center, Houston, Texas
Elizabeth M. Jaffee, Johns Hopkins University, Baltimore, Maryland
Mi-Ok Kim, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
J. Jack Lee, The University of Texas MD Anderson Cancer Center, Houston, Texas
H. Kim Lyerly, Duke University School of Medicine, Durham, North Carolina

Faculty Members
S. Gail Eckhardt, University of Colorado Cancer Center, Aurora, Colorado
Michael Glode, University of Colorado, Aurora, Colorado
Mithat Gönen, Memorial Sloan Kettering Cancer Center, New York, New York
Susan Halabi, Duke University Medical Center, Durham, North Carolina
Daniel F. Heitjan, UT Southwestern Medical School, Dallas, Texas
Karen L. Kelly, UC Davis Comprehensive Cancer Center, Sacramento, California
Shing M. Lee, Columbia University, New York, New York
Motomi Mori, Oregon Health & Science University, Portland, Oregon
Derek Raghavan, Levine Cancer Institute, Charlotte, North Carolina
Mary W. Redman, Fred Hutchinson Cancer Research Center, Seattle, Washington
Cornelia L. Trimble, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Kyle Wathen, Janssen Research Foundation, Titusville, New Jersey

The AACR is proud to offer a new innovative educational Workshop in 2015, designed specifically for biostatisticians. The Workshop is a week-long intensive and interactive learning opportunity, which will focus on the application of biostatistics in cancer clinical trials, and will be held in beautiful Lake Tahoe, California, from June 7-13, 2015.

The Workshop syllabus will cover many important and topical biostatistical aspects of cancer drug development, from translational clinical trials and drug combinations, to precision medicine, targeted agents, and comparative designs using biomarkers.

Admission to the Workshop is by competitive application and space is limited to 35-40 early-career biostatisticians.

Entry-level and junior faculty (who obtained their PhD within the past 5 years) biostatisticians working in cancer research, are encouraged to apply. Applicants may be from academia, government, nonprofit organizations, or industry. Priority will be given to individuals who seek to increase their exposure to oncology-centered biostatistics, and demonstrate a strong desire to pursue a career in cancer research and clinical trials. Applicants who are more advanced in their careers and considering a transition to cancer research, for whom the Workshop would also be beneficial, will also be considered.

This Workshop has been designed by a committee of internationally recognized experts in biostatistics and clinical oncology, led by Dr. Steven Piantadosi, MD, PhD, Phase One Foundation Chair and Director at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. With a faculty-to-student ratio of 1:2, the Workshop will promote close mentorship and networking among the attendees. The program will feature a combination of lecture sessions, case studies, and group problem-solving sessions.

Admission to the Workshop is by competitive application and space is limited to 35-40 early-career biostatisticians. Applications will be accepted from biostatisticians who obtained their PhDs within the past five years, who are currently involved in cancer research, and who wish to pursue additional training in oncology-related biostatistics. Applications from statisticians with more advanced careers who are considering transitioning to oncology-related research are also welcomed.

Please consult the tabs on the side for additional details of the program and for information about applying.  If you have any questions, please contact Virginie Adam, PhD, Senior Program Administrator, at 215-446-7266 or